Literature DB >> 22576021

Association study of a common variant near IRS1 with type 2 diabetes mellitus in Chinese Han population.

Yong Tang1, Xueyao Han, Xiuqin Sun, Chao Lv, Xiaomei Zhang, Wulan Guo, Qian Ren, Yingying Luo, Xiuying Zhang, Xianghai Zhou, Linong Ji.   

Abstract

The insulin receptor substrate-1 (IRS1) plays an important role in insulin signaling. A recent genome-wide association study identified rs2943641C>T as a susceptibility locus for type 2 diabetes mellitus (T2DM) in Caucasian patients. Therefore, we determined whether this common variant near IRS1 is also associated with the risk of T2DM and T2DM-related phenotypes in a Chinese Han population. A total of 2,290 unrelated Chinese Han individuals residing in Beijing were recruited in this study, including 1177 T2DM patients and 1113 subjects with normal glucose tolerance (control group). The single nucleotide polymorphism (SNP) was genotyped using a MassARRAY iPLEX system. The frequency of risk allele C was 0.929 in the control group and 0.939 in patients with T2DM. We found no association between the C allele of rs2943641 and T2DM in a recessive model [OR 1.14, 95 % confidence interval (CI) 0.89-1.45, P = 0.298], or after adjusting for sex, age, and body mass index (BMI) (OR 1.10, 95 % CI 0.85-1.43, P = 0.301). Analysis of the clinical features of the control subjects with normal glucose tolerance revealed that the 30-min plasma glucose level during a 75-g oral glucose tolerance test was significantly different between the CC and CT+TT genotypes (P = 0.017). Linear regression analysis showed that the 30-min plasma glucose levels was significantly and positively associated with the CC genotype after adjusting for sex, age, and BMI (β = 0.065, 95 % CI 0.009-0.654, P = 0.044). In addition, a potential association between this SNP and increased waist circumference (β = 1.337, 95 % CI -0.179 to 2.853, P = 0.084) was observed with adjustment for the sex and age. Our study was not able to demonstrate the association between rs2943641 near IRS1 and T2DM in a Chinese Han population. However, this SNP may be associated with postprandial hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22576021     DOI: 10.1007/s12020-012-9693-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

1.  Combined effects of FTO rs9939609 and MC4R rs17782313 on obesity and BMI in Chinese Han populations.

Authors:  Wei Huang; Yanlei Sun; Jiazhong Sun
Journal:  Endocrine       Date:  2010-11-10       Impact factor: 3.633

2.  Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population.

Authors:  Yun Liu; Zhe Liu; Yiqing Song; Daizhan Zhou; Di Zhang; Teng Zhao; Zhuo Chen; Lan Yu; Yifeng Yang; Guoyin Feng; Jun Li; Jie Zhang; Simin Liu; Zuofeng Zhang; Lin He; He Xu
Journal:  Obesity (Silver Spring)       Date:  2010-01-07       Impact factor: 5.002

Review 3.  Epidemic obesity and type 2 diabetes in Asia.

Authors:  Kun-Ho Yoon; Jin-Hee Lee; Ji-Won Kim; Jae Hyoung Cho; Yoon-Hee Choi; Seung-Hyun Ko; Paul Zimmet; Ho-Young Son
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

4.  Risk factors associated with the presence of diabetes in Chinese communities in Beijing.

Authors:  Xianghai Zhou; Linong Ji; Yingying Luo; Xueyao Han; Xiuying Zhang; Xiuqin Sun; Qian Ren; Qing Qiao
Journal:  Diabetes Res Clin Pract       Date:  2009-10-15       Impact factor: 5.602

5.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

Review 6.  The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family.

Authors:  Y Kaburagi; T Yamauchi; R Yamamoto-Honda; K Ueki; K Tobe; Y Akanuma; Y Yazaki; T Kadowaki
Journal:  Endocr J       Date:  1999-03       Impact factor: 2.349

7.  Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies.

Authors:  A Jellema; M P A Zeegers; E J M Feskens; P C Dagnelie; R P Mensink
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

8.  Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile.

Authors:  Tuomas O Kilpeläinen; M Carola Zillikens; Alena Stančákova; Francis M Finucane; Janina S Ried; Claudia Langenberg; Weihua Zhang; Jacques S Beckmann; Jian'an Luan; Liesbeth Vandenput; Unnur Styrkarsdottir; Yanhua Zhou; Albert Vernon Smith; Jing-Hua Zhao; Najaf Amin; Sailaja Vedantam; So-Youn Shin; Talin Haritunians; Mao Fu; Mary F Feitosa; Meena Kumari; Bjarni V Halldorsson; Emmi Tikkanen; Massimo Mangino; Caroline Hayward; Ci Song; Alice M Arnold; Yurii S Aulchenko; Ben A Oostra; Harry Campbell; L Adrienne Cupples; Kathryn E Davis; Angela Döring; Gudny Eiriksdottir; Karol Estrada; José Manuel Fernández-Real; Melissa Garcia; Christian Gieger; Nicole L Glazer; Candace Guiducci; Albert Hofman; Steve E Humphries; Bo Isomaa; Leonie C Jacobs; Antti Jula; David Karasik; Magnus K Karlsson; Kay-Tee Khaw; Lauren J Kim; Mika Kivimäki; Norman Klopp; Brigitte Kühnel; Johanna Kuusisto; Yongmei Liu; Osten Ljunggren; Mattias Lorentzon; Robert N Luben; Barbara McKnight; Dan Mellström; Braxton D Mitchell; Vincent Mooser; José Maria Moreno; Satu Männistö; Jeffery R O'Connell; Laura Pascoe; Leena Peltonen; Belén Peral; Markus Perola; Bruce M Psaty; Veikko Salomaa; David B Savage; Robert K Semple; Tatjana Skaric-Juric; Gunnar Sigurdsson; Kijoung S Song; Timothy D Spector; Ann-Christine Syvänen; Philippa J Talmud; Gudmar Thorleifsson; Unnur Thorsteinsdottir; André G Uitterlinden; Cornelia M van Duijn; Antonio Vidal-Puig; Sarah H Wild; Alan F Wright; Deborah J Clegg; Eric Schadt; James F Wilson; Igor Rudan; Samuli Ripatti; Ingrid B Borecki; Alan R Shuldiner; Erik Ingelsson; John-Olov Jansson; Robert C Kaplan; Vilmundur Gudnason; Tamara B Harris; Leif Groop; Douglas P Kiel; Fernando Rivadeneira; Mark Walker; Inês Barroso; Peter Vollenweider; Gérard Waeber; John C Chambers; Jaspal S Kooner; Nicole Soranzo; Joel N Hirschhorn; Kari Stefansson; H-Erich Wichmann; Claes Ohlsson; Stephen O'Rahilly; Nicholas J Wareham; Elizabeth K Speliotes; Caroline S Fox; Markku Laakso; Ruth J F Loos
Journal:  Nat Genet       Date:  2011-06-26       Impact factor: 38.330

9.  IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk.

Authors:  N Yiannakouris; J A Cooper; S Shah; F Drenos; H A Ireland; J W Stephens; K-W Li; R Elkeles; I F Godsland; M Kivimaki; A D Hingorani; M Kumari; P J Talmud; S E Humphries
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-09-14       Impact factor: 4.222

10.  Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project.

Authors:  Caroline S Fox; Nancy Heard-Costa; L Adrienne Cupples; Josée Dupuis; Ramachandran S Vasan; Larry D Atwood
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more
  7 in total

1.  Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis.

Authors:  José Manuel Sánchez-Maldonado; Ricardo Collado; Antonio José Cabrera-Serrano; Rob Ter Horst; Fernando Gálvez-Montosa; Inmaculada Robles-Fernández; Verónica Arenas-Rodríguez; Blanca Cano-Gutiérrez; Olivier Bakker; María Inmaculada Bravo-Fernández; Francisco José García-Verdejo; José Antonio López López; Jesús Olivares-Ruiz; Miguel Ángel López-Nevot; Laura Fernández-Puerta; José Manuel Cózar-Olmo; Yang Li; Mihai G Netea; Manuel Jurado; Jose Antonio Lorente; Pedro Sánchez-Rovira; María Jesús Álvarez-Cubero; Juan Sainz
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

2.  Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Anjana Munshi; Fawiziah Khalaf Alharbi; Yazeed Al-Sheikh; May Salem Alnbaheen
Journal:  Endocrine       Date:  2014-02-04       Impact factor: 3.633

3.  Associations between two single-nucleotide polymorphisms (rs1801278 and rs2943641) of insulin receptor substrate 1 gene and type 2 diabetes susceptibility: a meta-analysis.

Authors:  Qiuyan Li; Yuandong Qiao; Chuntao Wang; Guangfa Zhang; Xuelong Zhang; Lidan Xu
Journal:  Endocrine       Date:  2015-11-18       Impact factor: 3.633

Review 4.  Relationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Yan Zhang; Cheng-Ming Sun; Xiang-Qin Hu; Yue Zhao
Journal:  Sci Rep       Date:  2014-08-22       Impact factor: 4.379

5.  A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

Authors:  Rafael Ríos-Tamayo; Carmen Belén Lupiañez; Daniele Campa; Thomas Hielscher; Niels Weinhold; Joaquin Martínez-López; Andrés Jerez; Stefano Landi; Krzysztof Jamroziak; Charles Dumontet; Marzena Wątek; Fabienne Lesueur; Rui Manuel Reis; Herlander Marques; Artur Jurczyszyn; Ulla Vogel; Gabriele Buda; Ramón García-Sanz; Enrico Orciuolo; Mario Petrini; Annette J Vangsted; Federica Gemignani; Asta Försti; Hartmut Goldschmidt; Kari Hemminki; Federico Canzian; Manuel Jurado; Juan Sainz
Journal:  Oncotarget       Date:  2016-09-13

6.  COBLL1 and IRS1 Gene Polymorphisms and Placental Expression in Women with Gestational Diabetes.

Authors:  Przemyslaw Ustianowski; Damian Malinowski; Michał Czerewaty; Krzysztof Safranow; Maciej Tarnowski; Violetta Dziedziejko; Andrzej Pawlik
Journal:  Biomedicines       Date:  2022-08-09

7.  Insulin receptor substrate-1 (IRS-1) Gly927Arg: correlation with gestational diabetes mellitus in Saudi women.

Authors:  Khalid Khalaf Alharbi; Imran Ali Khan; Zeinab Abotalib; Malak Mohammed Al-Hakeem
Journal:  Biomed Res Int       Date:  2014-02-17       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.